文献速递流行病学与生物统计临床试验与 GCP

妊娠期新冠感染的临床表现、危险因素及母婴结局:动态系统综述与荟萃分析

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-09-01

该动态系统综述与荟萃分析纳入192项队列研究,评估妊娠及近期妊娠女性新冠感染的临床表现、危险因素和母婴结局。结果显示孕妇新冠症状较少但重症入住ICU和侵入性通气风险更高,合并症、高龄、高BMI和非白人种族与重症相关;感染孕妇早产、死亡及新生儿入住NICU风险增加。

要点

  • 孕妇新冠症状较少,但入住ICU和侵入性通气风险高于非妊娠育龄女性。
  • 高龄、高BMI、基础合并症、慢性高血压、糖尿病和子痫前期与妊娠期重症新冠相关。
  • 感染孕妇早产、死亡和新生儿入住NICU的风险增加。

核心结论

  • 妊娠及近期妊娠女性新冠症状表现较少,但重症入住ICU和侵入性通气风险高于非妊娠育龄女性。
  • 基础合并症、非白人种族、慢性高血压、糖尿病、高龄和高BMI是妊娠期重症新冠的危险因素。
  • 感染孕妇较未感染孕妇早产风险增加,并可能增加死亡和入住ICU风险,其婴儿更可能入住新生儿病房。

研究设计与样本

  • 动态系统综述与荟萃分析,检索Medline、Embase、Cochrane、WHO COVID-19等数据库及预印本等,截至2020年10月6日。
  • 纳入报告妊娠及近期妊娠女性疑似或确诊新冠的率、临床表现、危险因素及母婴结局的队列研究。
  • 共纳入192项研究,由至少两名研究者独立提取数据并评估质量,采用随机效应荟萃分析。

主要发现

  • 孕期新冠最常见临床表现为发热(40%)和咳嗽(41%)。
  • 孕妇新冠患者较非妊娠育龄女性更少出现症状(OR 0.28,95%CI 0.13至0.62;I2=42.9%)。
  • 孕妇新冠患者入住ICU(OR 2.13,95%CI 1.53至2.95;I2=71.2%)、侵入性通气(OR 2.59,95%CI 2.28至2.94;I2=0%)和ECMO(OR 2.02,95%CI 1.22至3.34;I2=0%)风险更高。

关键数值与推荐

  • 高龄(OR 1.83,95%CI 1.27至2.63;I2=43.4%)、高BMI(OR 2.37,95%CI 1.83至3.07;I2=0%)、任何基础合并症(OR 1.81,95%CI 1.49至2.20;I2=0%)与妊娠期重症新冠相关。
  • 慢性高血压(OR 2.0,95%CI 1.14至3.48;I2=0%)、糖尿病(OR 2.12,95%CI 1.62至2.78;I2=0%)、子痫前期(OR 4.21,95%CI 1.27至14.0;I2=0%)与妊娠期重症新冠相关。
  • 感染孕妇较未感染孕妇死亡风险增加(OR 2.85,95%CI 1.08至7.52;I2=0%)、入住ICU风险增加(OR 18.58,95%CI 7.53至45.82;I2=0%)、早产风险增加(OR 1.47,95%CI 1.14至1.91;I2=18.6%)。
  • 感染孕妇所生婴儿入住新生儿ICU风险更高(OR 4.89,95%CI 1.87至12.81;I2=96.2%)。

临床怎么用

  • 对妊娠及近期妊娠女性应警惕新冠重症风险,尤其合并高龄、高BMI、慢性高血压、糖尿病等基础疾病者。
  • 感染孕妇需加强监护,关注早产、重症及新生儿救治准备。
  • 临床决策可参考本综述的重症危险因素识别高危孕妇。

局限性

  • 纳入研究以队列研究为主,部分分析异质性较高(如入住ICU的I2=71.2%、新生儿ICU的I2=96.2%)。
  • 为动态系统综述,结论会随新证据更新。
  • 研究截至2020年10月6日,后续变异株等证据未涵盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19). DESIGN: Living systematic review and meta-analysis. DATA SOURCES: Medline, Embase, Cochrane database, WHO COVID-19 database, China National Knowledge Infrastructure (CNKI), and Wanfang databases from 1 December 2019 to 6 October 2020, along with preprint servers, social media, and reference lists. STUDY SELECTION: Cohort studies reporting the rates, clinical manifestations (symptoms, laboratory and radiological findings), risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed covid-19. DATA EXTRACTION: At least two researchers independently extracted the data and assessed study quality. Random effects meta-analysis was performed, with estimates pooled as odds ratios and proportions with 95% confidence intervals. All analyses will be updated regularly. RESULTS: 192 studies were included. Overall, 10% (95% confidence interval 7% to 12%; 73 studies, 67 271 women) of pregnant and recently pregnant women attending or admitted to hospital for any reason were diagnosed as having suspected or confirmed covid-19. The most common clinical manifestations of covid-19 in pregnancy were fever (40%) and cough (41%). Compared with non-pregnant women of reproductive age, pregnant and recently pregnant women with covid-19 were less likely to have symptoms (odds ratio 0.28, 95% confidence interval 0.13 to 0.62; I2=42.9%) or report symptoms of fever (0.49, 0.38 to 0.63; I2=40.8%), dyspnoea (0.76, 0.67 to 0.85; I2=4.4%) and myalgia (0.53, 0.36 to 0.78; I2=59.4%). The odds of admission to an intensive care unit (odds ratio 2.13, 1.53 to 2.95; I2=71.2%), invasive ventilation (2.59, 2.28 to 2.94; I2=0%) and need for extra corporeal membrane oxygenation (2.02, 1.22 to 3.34; I2=0%) were higher in pregnant and recently pregnant than non-pregnant reproductive aged women. Overall, 339 pregnant women (0.02%, 59 studies, 41 664 women) with confirmed covid-19 died from any cause. Increased maternal age (odds ratio 1.83, 1.27 to 2.63; I2=43.4%), high body mass index (2.37, 1.83 to 3.07; I2=0%), any pre-existing maternal comorbidity (1.81, 1.49 to 2.20; I2=0%), chronic hypertension (2.0, 1.14 to 3.48; I2=0%), pre-existing diabetes (2.12, 1.62 to 2.78; I2=0%), and pre-eclampsia (4.21, 1.27 to 14.0; I2=0%) were associated with severe covid-19 in pregnancy. In pregnant women with covid-19, increased maternal age, high body mass index, non-white ethnicity, any pre-existing maternal comorbidity including chronic hypertension and diabetes, and pre-eclampsia were associated with serious complications such as admission to an intensive care unit, invasive ventilation and maternal death. Compared to pregnant women without covid-19, those with the disease had increased odds of maternal death (odds ratio 2.85, 1.08 to 7.52; I2=0%), of needing admission to the intensive care unit (18.58, 7.53 to 45.82; I2=0%), and of preterm birth (1.47, 1.14 to 1.91; I2=18.6%). The odds of admission to the neonatal intensive care unit (4.89, 1.87 to 12.81, I2=96.2%) were higher in babies born to mothers with covid-19 versus those without covid-19. CONCLUSION: Pregnant and recently pregnant women with covid-19 attending or admitted to the hospitals for any reason are less likely to manifest symptoms such as fever, dyspnoea, and myalgia, and are more likely to be admitted to the intensive care unit or needing invasive ventilation than non-pregnant women of reproductive age. Pre-existing comorbidities, non-white ethnicity, chronic hypertension, pre-existing diabetes, high maternal age, and high body mass index are risk factors for severe covid-19 in pregnancy. Pregnant women with covid-19 versus without covid-19 are more likely to deliver preterm and could have an increased risk of maternal death and of being admitted to the intensive care unit. Their babies are more likely to be admitted to the neonatal unit. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178076. READERS' NOTE: This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication. This version is update 1 of the original article published on 1 September 2020 (BMJ 2020;370:m3320), and previous updates can be found as data supplements (https://www.bmj.com/content/370/bmj.m3320/related#datasupp). When citing this paper please consider adding the update number and date of access for clarity.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020. PMID: 32873575. doi:10.1136/bmj.m3320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。